Alternative names (17)
canBeInhibitedBy • inactivated by • inhibit • inhibited by • inhibition • inhibition effect • inhibition leads to • inhibition used for • inhibitionBy • inhibitionEffect • inhibitor • inhibits • is inhibited by • is inhibitor of • isInhibitedBy • isInhibitorOf • notInhibitedBy • moreRandom triples
| Subject | Object |
|---|---|
| gptkb:Tumor_Necrosis_Factor | gptkb:thalidomide |
| gptkb:glycogen_phosphorylase | gptkb:ATP |
| gptkb:Il-4 | Th1 cell development |
| gptkb:ATR_kinase | VE-821 |
| gptkb:VEGFR-1 | gptkb:ranibizumab |
| gptkb:CYP450_enzymes | azole antifungals |
| gptkb:IMP-type_metallo-beta-lactamase | gptkb:clavulanic_acid |
| gptkb:AURKA | VX-680 |
| gptkb:Bcl-w | caspase activation |
| gptkb:3CLpro | gptkb:boceprevir |
| gptkb:VEGFR-2 | gptkb:sunitinib |
| gptkb:IDO | 1-methyl-tryptophan |
| gptkb:C1INH | gptkb:C1r |
| gptkb:SHV_beta-lactamase | gptkb:clavulanic_acid |
| gptkb:OXA-48 | limited beta-lactamase inhibitors |
| gptkb:CAMKII | gptkb:KN-93 |
| gptkb:NF-kB | IκB proteins |
| gptkb:LIM_kinase | LIMKi 3 |
| gptkb:Cdk1 | Wee1 kinase |
| gptkb:HDAC11 | gptkb:FT895 |